Frontiers | Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
商品説明・詳細
送料・お届け
商品情報
Frontiers | Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits,313KB,Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer | Oncogene,Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects | Nature Reviews Urology,Distant Metastasis is the Dominant Cause of Treatment Failure after Lateral Lymph Node Dissection in Patients with Lateral Lymph Node Metastasis: Results of the Large Multicenter Lateral Node Study in China